slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 204,991-205,020
Pages 10,126
Rows per page 30
Component
204,991-205,020 of 303,780
43
Includes a map of global offices, a timeline of international expansion, and three bar charts showing international financial performance metrics.Silicon Valley Bank | Results Presentation Deck | 52 slides · SVB
Conference presentation Investor relations 1 hit
44
The slide uses a grouped bar chart for ROE and a multi-line chart for TSR to demonstrate historical outperformance.Silicon Valley Bank | Results Presentation Deck | 52 slides · SVB
Conference presentation Investor relations 1 hit
46
Silicon Valley Bank | Results Presentation Deck | 52 slidesSilicon Valley Bank | Results Presentation Deck | 52 slides · SVB
Conference presentation Investor relations 1 hit
47
Silicon Valley Bank | Results Presentation Deck | 52 slidesSilicon Valley Bank | Results Presentation Deck | 52 slides · SVB
Conference presentation Investor relations 1 hit
48
Silicon Valley Bank | Results Presentation Deck | 52 slidesSilicon Valley Bank | Results Presentation Deck | 52 slides · SVB
Conference presentation Investor relations 1 hit
51
Silicon Valley Bank | Results Presentation Deck | 52 slidesSilicon Valley Bank | Results Presentation Deck | 52 slides · SVB
Conference presentation Investor relations 1 hit
52
Silicon Valley Bank | Results Presentation Deck | 52 slidesSilicon Valley Bank | Results Presentation Deck | 52 slides · SVB
Conference presentation Investor relations 1 hit
01
Silo Pharma | Investor Presentation Deck | 24 slidesSilo Pharma | Investor Presentation Deck | 24 slides · Silo Pharma
Pitch deck Investor relations 1 hit
02
Silo Pharma | Investor Presentation Deck | 24 slidesSilo Pharma | Investor Presentation Deck | 24 slides · Silo Pharma
Pitch deck Investor relations 1 hit
03
The slide uses a molecular structure graphic to reinforce the pharmaceutical theme.Silo Pharma | Investor Presentation Deck | 24 slides · Silo Pharma
Pitch deck Investor relations Beat · Problem1 hit
04
Silo Pharma | Investor Presentation Deck | 24 slidesSilo Pharma | Investor Presentation Deck | 24 slides · Silo Pharma
Pitch deck Investor relations Beat · Problem1 hit
05
The slide maps specific university/corporate partners to their respective drug development programs (SP-26, SPU-16, SPU-21, SPC-14, SPC-15, Generic psilocybin).Silo Pharma | Investor Presentation Deck | 24 slides · Silo Pharma
Pitch deck Investor relations Beat · Problem1 hit
06
Silo Pharma | Investor Presentation Deck | 24 slidesSilo Pharma | Investor Presentation Deck | 24 slides · Silo Pharma
Pitch deck Investor relations 1 hit
07
The slide lists specific patent numbers and filing dates to establish credibility.Silo Pharma | Investor Presentation Deck | 24 slides · Silo Pharma
Pitch deck Investor relations 1 hit
08
Silo Pharma | Investor Presentation Deck | 24 slidesSilo Pharma | Investor Presentation Deck | 24 slides · Silo Pharma
Pitch deck Investor relations 1 hit
09
The slide outlines the market opportunity, technology, and specific applications for the SP-26 program.Silo Pharma | Investor Presentation Deck | 24 slides · Silo Pharma
Pitch deck Investor relations Beat · Solution1 hit
10
Slide 10 of a pitch deck for Silo Pharma.Silo Pharma | Investor Presentation Deck | 24 slides · Silo Pharma
Pitch deck Investor relations Beat · Solution1 hit
14
The slide outlines a specific research partnership and its scope.Silo Pharma | Investor Presentation Deck | 24 slides · Silo Pharma
Pitch deck Investor relations Beat · Solution1 hit
15
Silo Pharma | Investor Presentation Deck | 24 slidesSilo Pharma | Investor Presentation Deck | 24 slides · Silo Pharma
Pitch deck Investor relations Beat · Team1 hit
16
Silo Pharma | Investor Presentation Deck | 24 slidesSilo Pharma | Investor Presentation Deck | 24 slides · Silo Pharma
Pitch deck Investor relations Beat · Team1 hit
17
Silo Pharma | Investor Presentation Deck | 24 slidesSilo Pharma | Investor Presentation Deck | 24 slides · Silo Pharma
Pitch deck Investor relations Beat · Team1 hit
18
Silo Pharma | Investor Presentation Deck | 24 slidesSilo Pharma | Investor Presentation Deck | 24 slides · Silo Pharma
Pitch deck Investor relations Beat · Team1 hit
19
This is a placeholder or section divider slide.Silo Pharma | Investor Presentation Deck | 24 slides · Silo Pharma
Pitch deck Investor relations 1 hit
20
Slide 20 of the deck.Silo Pharma | Investor Presentation Deck | 24 slides · Silo Pharma
Pitch deck Investor relations 1 hit
21
Silo Pharma | Investor Presentation Deck | 24 slidesSilo Pharma | Investor Presentation Deck | 24 slides · Silo Pharma
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
22
The table highlights SiloPharma's unique 505(b)(2) regulatory pathway compared to peers.Silo Pharma | Investor Presentation Deck | 24 slides · Silo Pharma
Pitch deck Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
23
Silo Pharma | Investor Presentation Deck | 24 slidesSilo Pharma | Investor Presentation Deck | 24 slides · Silo Pharma
Pitch deck Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
24
Silo Pharma | Investor Presentation Deck | 24 slidesSilo Pharma | Investor Presentation Deck | 24 slides · Silo Pharma
Pitch deck Investor relations 1 hit
01
Silvergate Bank | Results Presentation Deck | 10 slidesSilvergate Bank | Results Presentation Deck | 10 slides · Silvergate Capital Corporation
Conference presentation Investor relations Beat · What Is1 hit
02
Silvergate Bank | Results Presentation Deck | 10 slidesSilvergate Bank | Results Presentation Deck | 10 slides · Silvergate Capital Corporation
Conference presentation Investor relations Beat · What Is1 hit